ReviewFrontiers in immunology2021

BTK Inhibitors in Chronic Lymphocytic Leukemia: Biological Activity and Immune Effects.

Marzia Palma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.